alfuzosin has been researched along with Syndrome in 13 studies
alfuzosin: structure given in first source
Syndrome: A characteristic symptom complex.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A double-blind, placebo-controlled study in 20 patients with 'prostatitis syndromes' and confirmed urodynamic abnormalities using the alpha 1-receptor-blocking compound alfuzosin is reported." | 9.07 | Research in 'prostatitis syndromes': the use of alfuzosin (a new alpha 1-receptor-blocking agent) in patients mainly presenting with micturition complaints of an irritative nature and confirmed urodynamic abnormalities. ( de Boo, T; de la Rosette, JJ; Debruyne, FM; Karthaus, HF; van Kerrebroeck, PE, 1992) |
| "To compare the incidence of intraoperative floppy-iris syndrome (IFIS) in men exposed to tamsulosin and men exposed to alfuzosin and evaluate the effect of IFIS on the complication rate of cataract surgery." | 7.74 | Intraoperative floppy-iris syndrome associated with alpha1-adrenoreceptors: comparison of tamsulosin and alfuzosin. ( Blouin, J; Blouin, MC; Dragomir, A; Lapointe, A; Perreault, S, 2007) |
| "Tamsulosin was more effective than alfuzosin at blocking adrenergic contraction of the iris dilator muscle in pigmented rabbits." | 5.35 | Comparative effect of alfuzosin and tamsulosin on the contractile response of isolated rabbit prostatic and iris dilator smooth muscles: possible model for intraoperative floppy-iris syndrome. ( Chang, DF; Lluel, P; Palea, S; Regnier, A; Rekik, M, 2008) |
| "A double-blind, placebo-controlled study in 20 patients with 'prostatitis syndromes' and confirmed urodynamic abnormalities using the alpha 1-receptor-blocking compound alfuzosin is reported." | 5.07 | Research in 'prostatitis syndromes': the use of alfuzosin (a new alpha 1-receptor-blocking agent) in patients mainly presenting with micturition complaints of an irritative nature and confirmed urodynamic abnormalities. ( de Boo, T; de la Rosette, JJ; Debruyne, FM; Karthaus, HF; van Kerrebroeck, PE, 1992) |
| "To evaluate risk factors (hypertension, diabetes mellitus, and current tamsulosin, alfuzosin, terazosin, or doxazosin use) for intraoperative floppy iris syndrome (IFIS) in patients undergoing phacoemulsification cataract surgery." | 4.87 | Risk factors for intraoperative floppy iris syndrome: a meta-analysis. ( Chatziralli, IP; Sergentanis, TN, 2011) |
| "To compare the incidence of intraoperative floppy-iris syndrome (IFIS) in men exposed to tamsulosin and men exposed to alfuzosin and evaluate the effect of IFIS on the complication rate of cataract surgery." | 3.74 | Intraoperative floppy-iris syndrome associated with alpha1-adrenoreceptors: comparison of tamsulosin and alfuzosin. ( Blouin, J; Blouin, MC; Dragomir, A; Lapointe, A; Perreault, S, 2007) |
| "Tamsulosin was more effective than alfuzosin at blocking adrenergic contraction of the iris dilator muscle in pigmented rabbits." | 1.35 | Comparative effect of alfuzosin and tamsulosin on the contractile response of isolated rabbit prostatic and iris dilator smooth muscles: possible model for intraoperative floppy-iris syndrome. ( Chang, DF; Lluel, P; Palea, S; Regnier, A; Rekik, M, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 9 (69.23) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Pierce, H | 1 |
| Fainberg, J | 1 |
| Gaffney, C | 1 |
| Aboukhashaba, A | 1 |
| Khan, A | 1 |
| Kashanian, J | 1 |
| Liu, S | 1 |
| Yu, Y | 1 |
| Gao, Y | 1 |
| Yang, X | 1 |
| Pang, Z | 1 |
| Arikan, G | 1 |
| Demir, O | 1 |
| Yaman, A | 1 |
| Bozkurt, O | 1 |
| Saatci, AO | 1 |
| Durak, I | 1 |
| Esen, A | 1 |
| Mamalis, N | 1 |
| Chatziralli, IP | 1 |
| Sergentanis, TN | 1 |
| Sinha, D | 1 |
| Arunkalaivanan, A | 1 |
| Schwinn, DA | 1 |
| Afshari, NA | 1 |
| Settas, G | 1 |
| Fitt, AW | 1 |
| Cheung, CM | 1 |
| Awan, MA | 1 |
| Peh, KK | 1 |
| Sandramouli, S | 1 |
| Blouin, MC | 1 |
| Blouin, J | 1 |
| Perreault, S | 1 |
| Lapointe, A | 1 |
| Dragomir, A | 1 |
| Palea, S | 1 |
| Chang, DF | 1 |
| Rekik, M | 1 |
| Regnier, A | 1 |
| Lluel, P | 1 |
| Nickel, JC | 1 |
| de la Rosette, JJ | 1 |
| Karthaus, HF | 1 |
| van Kerrebroeck, PE | 1 |
| de Boo, T | 1 |
| Debruyne, FM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effects of Systemic Alfuzosin and Tamsulosin Hydrochloride on Choroidal Thickness and Pupil Diameter Sizes in Cases With Benign Prostatic Hyperplasia[NCT03144596] | Phase 4 | 63 participants (Actual) | Interventional | 2015-10-29 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for alfuzosin and Syndrome
| Article | Year |
|---|---|
Risk factors for intraoperative floppy iris syndrome: a meta-analysis.
Topics: Adrenergic alpha-1 Receptor Antagonists; Diabetes Complications; Doxazosin; Humans; Hypertension; In | 2011 |
Role of alpha1-blockers in chronic prostatitis syndromes.
Topics: Adrenergic alpha-Antagonists; Anti-Infective Agents; Bacterial Infections; Chronic Disease; Clinical | 2008 |
2 trials available for alfuzosin and Syndrome
| Article | Year |
|---|---|
Decreased urinary glycosaminoglycan excretion following alfuzosin treatment on ureteral stent-related symptoms: a prospective, randomized, placebo-controlled study.
Topics: Adult; Double-Blind Method; Female; Glycosaminoglycans; Hematuria; Humans; Lower Urinary Tract Sympt | 2016 |
Research in 'prostatitis syndromes': the use of alfuzosin (a new alpha 1-receptor-blocking agent) in patients mainly presenting with micturition complaints of an irritative nature and confirmed urodynamic abnormalities.
Topics: Adrenergic alpha-Antagonists; Adult; Double-Blind Method; Humans; Male; Middle Aged; Prostatitis; Qu | 1992 |
9 other studies available for alfuzosin and Syndrome
| Article | Year |
|---|---|
Postorgasmic illness syndrome: potential new treatment options for a rare disorder.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Humans; Male; Orgasm; Prazosin; Quinazolines; Sexual | 2020 |
The effect of various alpha1-adrenergic receptor antagonists on pupillary dilation.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Doxazosin; Humans; Iris Disea | 2008 |
Intraoperative floppy-iris syndrome associated with systemic alpha blockers.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Cataract Extraction; Doxazosi | 2008 |
Urethral syndrome: response to alpha-adrenergic blocking agents.
Topics: Adrenergic alpha-Antagonists; Adult; Depression; Female; Humans; Quinazolines; Remission Induction; | 2006 |
Alpha1-adrenergic antagonists and floppy iris syndrome: tip of the iceberg?
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Do | 2005 |
Intraoperative floppy iris syndrome in a patient taking alfuzosin for benign prostatic hypertrophy.
Topics: Adrenergic alpha-Antagonists; Aged, 80 and over; Cataract Extraction; Humans; Intraoperative Complic | 2006 |
Incidence of intraoperative floppy iris syndrome in patients on either systemic or topical alpha1-adrenoceptor antagonist.
Topics: Administration, Topical; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adul | 2007 |
Intraoperative floppy-iris syndrome associated with alpha1-adrenoreceptors: comparison of tamsulosin and alfuzosin.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Humans; Incidence; Intr | 2007 |
Comparative effect of alfuzosin and tamsulosin on the contractile response of isolated rabbit prostatic and iris dilator smooth muscles: possible model for intraoperative floppy-iris syndrome.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Disease Models, Anim | 2008 |